With its goal to expedite the decision-making process for medical professionals while providing better accuracy for diagnoses, VUNO has developed VUNO-MED™, a medical data analysis solution built on AI technology. In collaboration with South Korea’s largest hospitals and pharmaceutical companies, as well as radiologists and medical scientists, VUNO has utilized medical imaging to create the VUNO-MED™ platform, which comprises the Bone Age, Chest X-ray, Chest CT, and Lung Quant series. With its own deep learning engine, VUNO-MED™ develops diagnoses-assisting solutions and services and data analysis based on X-ray features, CT scans, and a bio-signal monitoring system.
VUNO is available in large hospitals as an on-premise solution, and as a cloud-based service to clinics. The VUNO-MED™ Bone Age series is the first among AI-based medical diagnosis solutions and devices in South Korea to be approved by the Ministry of Food and Drug Safety and has received accolades for improving reading speed by 40% and increasing reading accuracy by 8%.